Back to Peptides
Weight Management
Cagrilintide
Cagrilintide is a long-acting amylin analog that has gained attention in obesity research. Amylin is a hormone co-secreted with insulin that regulates appetite and gastric emptying. Studies have explored cagrilintide both as a standalone therapy and in combination with GLP-1 agonists for enhanced weight loss effects.
Weight ManagementAppetiteAmylinSatiety
Research Benefits
Potent appetite suppression through amylin pathway
Gastric emptying delay for satiety enhancement
Synergistic effects with GLP-1 agonists documented
Significant weight loss observed in clinical trials
Axo's Research Digest
An AI-generated, plain-English overview of what the research explores for Cagrilintide — and how mature that evidence is.